Medtronic PLC
NYSE:MDT

Watchlist Manager
Medtronic PLC Logo
Medtronic PLC
NYSE:MDT
Watchlist
Price: 87.63 USD -1.52% Market Closed
Market Cap: 112.4B USD

MDT's latest stock split occurred on Sep 27, 1999

The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.

The adjusted shares began trading on Sep 27, 1999. This was MDT's 8th stock split, following the previous one in Sep 15, 1997.

Last Splits:
Sep 27, 1999
2-for-1
Sep 15, 1997
2-for-1
Sep 29, 1995
2-for-1
Oct 3, 1994
2-for-1
Sep 30, 1994
2-for-1
Pre-Split Price
N/A
Post-Split Price
31.659
Before
After
Last Splits:
Sep 27, 1999
2-for-1
Sep 15, 1997
2-for-1
Sep 29, 1995
2-for-1
Oct 3, 1994
2-for-1
Sep 30, 1994
2-for-1

Medtronic PLC
Stock Splits History

MDT Stock Splits Timeline
Sep 27, 1999
Sep 27, 1999
Split 2-for-1
x2
Pre-Split Price
N/A
Post-Split Price
31.659
Before
After
Sep 15, 1997
Sep 15, 1997
Split 2-for-1
x2
Pre-Split Price
N/A
Post-Split Price
31.659
Before
After
Sep 29, 1995
Sep 29, 1995
Split 2-for-1
x2
Pre-Split Price
N/A
Post-Split Price
31.659
Before
After
Oct 3, 1994
Oct 3, 1994
Split 2-for-1
x2
Pre-Split Price
N/A
Post-Split Price
31.659
Before
After
Sep 30, 1994
Sep 30, 1994
Split 2-for-1
x2
Pre-Split Price
N/A
Post-Split Price
31.659
Before
After
Aug 30, 1991
Aug 30, 1991
Split 2-for-1
x2
Pre-Split Price
N/A
Post-Split Price
31.659
Before
After
Aug 31, 1989
Aug 31, 1989
Split 2-for-1
x2
Pre-Split Price
N/A
Post-Split Price
31.659
Before
After
Aug 1, 1980
Aug 1, 1980
Split 2-for-1
x2
Pre-Split Price
N/A
Post-Split Price
31.659
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Mar 28, 2025
Yellow Hat Ltd
OTC:YLLWF
2-for-1
x2
16.93 8.465 USD 8.465 8.465 USD
Mar 25, 2025
CMC Metals Ltd
XTSX:CMB
1-for-10
/10
0.02 0.2 CAD 0.25 0.25 CAD
Mar 25, 2025
Rent.com.au Ltd
ASX:RNT
63-for-62
x1.0161290322581
0.021 0.0207 AUD 0.018 0.018 AUD
Mar 25, 2025
U
US Critical Metals Corp
OTC:USCMF
1-for-2
/2
0.06 0.15 USD 0.1127 0.1127 USD
Mar 25, 2025
CMC Metals Ltd
F:ZM5P
1-for-10
/10
0.0038 0.038 EUR 0.009 0.009 EUR
Load More

Medtronic PLC
Glance View

Economic Moat
Narrow
Market Cap
112.5B USD
Industry
Health Care

In the intricate world of medical technology, Medtronic PLC stands tall as one of the foremost innovators transforming the landscape of healthcare. Founded in 1949 as a humble medical supply repair shop in Minnesota, Medtronic has grown into a global titan, driven by the enduring mission to alleviate pain, restore health, and extend life. The company's breadth is vast, touching nearly every aspect of patient care, from advanced robotic-assisted surgery systems to sophisticated insulin pumps. At its core, Medtronic thrives on relentless research and development, continually bridging the gap between cutting-edge technology and practical medical solutions. By forging deep alliances with healthcare providers and systems around the globe, the company ensures its innovations are not only groundbreaking but also widely accessible. The company's financial engine purrs to life primarily through the development and sale of medical devices across four major segments: Cardiac and Vascular Group, Minimally Invasive Therapies, Restorative Therapies Group, and Diabetes Group. Each unit meticulously focuses on innovating and providing solutions relevant to its field, ensuring a diversified portfolio with robust pipelines. For instance, within the Cardiac and Vascular Group, Medtronic supplies life-saving products like pacemakers and stents while also exploring breakthrough therapies such as transcatheter heart valves. By capitalizing on a global presence, the company strategically taps into both mature markets in North America and Europe and emerging markets across Asia and Latin America, thereby driving substantial revenue streams. Through this multifaceted operational framework, Medtronic not only sustains its market dominance but also reinvests in the future of medical technology, symbolizing a perpetual cycle of growth and innovation.

MDT Intrinsic Value
99.38 USD
Undervaluation 12%
Intrinsic Value
Price
Back to Top